JHOP Articles

Skip to main content

FDA Updates

Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer

FDA Updates

Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer

FDA Updates

Trodelvy Receives New Indication for Advanced Urothelial Cancer

FDA Updates

Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma

IWTI Best Practices in GU Navigation

Interview with the Innovators

The Multidisciplinary Care Approach to Cancer Care Management

Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN

IWTI Best Practices in GU Navigation

Interview with the Innovators

The Clinical Advantages of Combination Therapies in Advanced RCC

Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN

IWTI Best Practices in GU Navigation

Interview with the Innovators

Improving the Patient Experience by Helping Patients Navigate Their Cancer Care

Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN

Original Research, Dose Escalation/Reduction, Adverse Events, Methotrexate

Assessment of High-Dose Methotrexate Management Guideline in Adults with Cancer at an Academic Medical Center

Andrew Kowalski, PharmD, BCOP, Sara Mohamed Jaszczur, PharmD, BCOP, Michelle Nadeau-Nguyen, PharmD, BCPS, Man-Yee Merl, PharmD, BCOP

Andrew Kowalski, PharmD, BCOP; Sara Mohamed Jaszczur, PharmD, BCOP; Michelle Nadeau-Nguyen, PharmD, BCPS; Man Yee Merl, PharmD, BCOP

FDA Updates, Lymphoma

Yescarta First CAR T-Cell Therapy Approved for Follicular Lymphoma

Case Reports, Lung Cancer, Adverse Events, Chemotherapy

Facial Edema Preceding Acute Renal Injury Linked to Pemetrexed Therapy in a Patient with Lung Cancer

Matthew S. Mattila, PharmD, BCPS, BCOP, Joel M. Lundberg, MD, FACP

Matthew S. Mattila, PharmD, BCPS, BCOP; Joel H. Lundberg, MD, FACP

Page 88 of 196
Results 871 - 880 of 1954